Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.84 |
| ▸ | USP8 | P40818 | 1/20 | 0.84 |
| ▸ | USP5 | P45974 | 1/20 | 0.84 |
| ▸ | USP4 | Q13107 | 1/20 | 0.84 |
| ▸ | USP7 | Q93009 | 1/20 | 0.84 |
| ▸ | MYC | P01106 | 2/20 | 0.32 |
| ▸ | WDR5 | P61964 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13024499 | 0.92 | USP2 (1.00) | USP2USP8USP5USP4USP7 | |
| SCHEMBL13065926 | 0.84 | USP2 (0.84) | USP2USP8USP5USP4USP7 | |
| SCHEMBL13985248 | 0.78 | USP2 (0.74) | USP2USP8USP5USP4USP7 | |
| SCHEMBL10412909 | 0.69 | USP2 (0.60) | USP2USP8USP5USP4USP7 | |
| SCHEMBL11173991 | 0.66 | USP2 (0.56) | USP2USP8USP5USP4USP7 | |
| SCHEMBL9387702 | 0.64 | USP2 (0.53) | USP2USP8USP5USP4USP7 | |
| SCHEMBL10413718 | 0.61 | USP2 (0.50) | USP2USP8USP5USP4USP7 | |
| SCHEMBL11367939 | 0.58 | USP2 (0.47) | USP2USP8USP5USP4USP7 | |
| SCHEMBL11373307 | 0.58 | USP2 (0.47) | USP2USP8USP5USP4USP7 | |
| SCHEMBL11373902 | 0.58 | USP2 (0.47) | USP2USP8USP5USP4USP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160264933-A1 | CELL DIFFERENTIATION MARKER AND ITS USES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIQUE (CNRS) | 2016-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160264933-A1 | CELL DIFFERENTIATION MARKER AND ITS USES | MYADM, USP3, USP2 | USP2 3/4885USP8 22/4885USP5 21/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.